Table 2.

The clinicopathological characteristics according to SII-PNI scores.

Characteristics	SII-PNI score			χ2	p-Value
	0 (n=57)	1 (n=44)	2 (n=23)
Gender				1.566	0.457
Male	45	31	19
Female	12	13	4
Age (y)				2.936	0.231
<64	29	27	9
≥64	28	17	14
Smoking history
Ever	22	17	14	3.792	0.150
Never	35	27	9
BMI				1.226	0.874
<18.5	3	4	1
18.5–24.9	42	29	6
≥25	12	11	6
Histology				7.153	0.128
Adenocarcinoma	42	30	12
Squamous carcinoma	15	13	9
Other histology	0	1	2
TNM stage				2.602	0.272
III	16	7	7
IV	41	37	16
ECOG PS				1.288	0.525
0	15	13	9
1	42	31	14
Chemotherapy regimen				1.526	0.958
Platinum + pemetrexed	38	28	15
Platinum + paclitaxel	10	6	3
Platinum + gemcitabine	5	7	3
Platinum + docetaxel	4	3	2
Response to chemotherapy				14.300	0.006
PR	19	4	2
SD	32	27	16
PD	6	13	5
Targeted therapy				1.397	0.497
No	39	34	15
Yes	18	10	8
Immunotherapy				5.095	0.078
No	45	40	22
Yes	12	4	1
Antiangiogenic therapy				3.436	0.179
No	40	29	20
Yes	17	15	3